UMIN ID: UMIN000042015
Registered date:07/10/2020
Japan REgistry for Adult subjeCTs of SMA
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | Spinal Muscular Atrophy |
Date of first enrollment | 2020/11/01 |
Target sample size | 150 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Collecting longitudinal data of Motor function and QOL/PRO |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1)SMA patients who have psychiatric disorder. 2)SMA patients who are judged as unsuitable for the study by the investigator. |
Related Information
Primary Sponsor | Nagoya University Graduate School of Medicine Biogen Japan Ltd. Chugai Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Biogen Japan Ltd. Chugai Pharmaceutical Co., Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Satona Otake |
Address | Akasaka Intercity,1-11-44 Akasaka, Minato-ku,Tokyo, Japan Japan 107-0052 |
Telephone | 03-4362-4500 |
sma_adult_registry@mebix.co.jp | |
Affiliation | Mebix, Inc. Research Promotion Group |
scientific contact | |
Name | Masahisa Katsuno |
Address | 65 Tsurumai Showa, Nagoya, Aichi, Japan Japan |
Telephone | 052-744-2389 |
ka2no@med.nagoya-u.ac.jp | |
Affiliation | Nagoya University Graduate School of Medicine Department of Neurology |